Suppr超能文献

甲状腺相关激素在甲状腺功能障碍疾病与骨质疏松症之间的中介作用:一项中介孟德尔随机化研究

The mediating role of thyroid-related hormones between thyroid dysfunction diseases and osteoporosis: a mediation mendelian randomization study.

作者信息

Liu Ruikang, Fan Weiming, Hu Jiaming, Xu Ke, Huang Zhijian, Liu Yang, Sun Chiyun

机构信息

School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.

Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.

出版信息

Sci Rep. 2025 Feb 3;15(1):4121. doi: 10.1038/s41598-025-88412-7.

Abstract

The links between Thyroid dysfunction diseases (TDFDs) and osteoporosis (OP) has received widespread attention, but the causal relationships and mediating factors have not been systematically studied. We used two-sample Mendelian randomization (MR) analysis to elucidate the causal relationship between TDFDs and OP. Moreover, we performed mediation MR analyses to explore the role of thyroid-related hormones and OP risk factors in the association between TDFDs and OP. Two sample MR analyses showed that hyperthyroidism increased OP (OR = 1.080, 95% CI 1.026 to 1.137; P = 0.0032) risk. Hypothyroidism increases OP (OR = 1.183, 95% CI 1.125 to 1.244; P < 0.0001) risk. Furthermore, mediation analysis revealed that TSH mediated 5.314% of the relationship between hypothyroidism and OP. In contrast, FT4 mediated 9.670% of the relationship between hyperthyroidism and OP. In European populations, TDFDs may increase OP risk. TSH mediates in the causal association between hypothyroidism and OP, and similarly, FT4 mediates in the causal link between hyperthyroidism and OP. Our findings underscore the significance of improving integrative care for individuals with TDFDs to mitigate the risk of OP. It is essential to maintain stable levels of thyroid hormones and closely monitor bone health to effectively mitigate and prevent OP.

摘要

甲状腺功能障碍性疾病(TDFDs)与骨质疏松症(OP)之间的联系已受到广泛关注,但因果关系和中介因素尚未得到系统研究。我们采用两样本孟德尔随机化(MR)分析来阐明TDFDs与OP之间的因果关系。此外,我们进行了中介MR分析,以探讨甲状腺相关激素和OP危险因素在TDFDs与OP关联中的作用。两样本MR分析表明,甲状腺功能亢进会增加OP风险(OR = 1.080,95% CI为1.026至1.137;P = 0.0032)。甲状腺功能减退会增加OP风险(OR = 1.183,95% CI为1.125至1.244;P < 0.0001)。此外,中介分析显示,促甲状腺激素(TSH)介导了甲状腺功能减退与OP之间5.314%的关系。相比之下,游离甲状腺素(FT4)介导了甲状腺功能亢进与OP之间9.670%的关系。在欧洲人群中,TDFDs可能会增加OP风险。TSH介导甲状腺功能减退与OP之间的因果关联,同样,FT4介导甲状腺功能亢进与OP之间的因果联系。我们的研究结果强调了改善对TDFDs患者的综合护理以降低OP风险的重要性。维持甲状腺激素水平稳定并密切监测骨骼健康对于有效减轻和预防OP至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fde8/11791035/f77400106087/41598_2025_88412_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验